Table: Taiko Pharmaceutical -6-MTH group results
Nov 12 (Reuters)-
Taiko Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2015 Sep 30, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.24 3.65 9.20
(-11.3 pct) (-13.9 pct) (+2.5 pct)
Operating 397 mln 969 mln 1.55
(-59.0 pct) (-32.7 pct) (-39.4 pct)
Recurring 405 mln 1.08 1.45
(-62.5 pct) (-25.5 pct) (-47.8 pct)
Net 123 mln 702 mln 1.00
(-82.4 pct) (-37.1 pct) (-43.5 pct)
EPS 9.63 yen 55.33 yen 78.24 yen
EPS Diluted 9.38 yen 54.07 yen
Ann Div 25.00 yen 15.00 yen
-Q2 div NIL NIL
-Q4 div 25.00 yen 15.00 yen
NOTE - Taiko Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T
((Tokyo Headline News Desk +813 6441 1812))